Fiji vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Fiji rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Sri Lanka
How they compare
Fiji currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 7 times across 17 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Sri Lanka ranks 1st of 180 countries.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 88.7% | 22.0% | Sri Lanka |
| 2010s | 48.1% | 85.6% | 37.5% | Sri Lanka |
| 2020s | 77.2% | 81.5% | 4.3% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Sri Lanka?
- Fiji, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Sri Lanka?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Sri Lanka?
- 17 years are reported by both, from 2006 to 2024.
- How do Fiji and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.